The FDA says ecstasy is a ‘breakthrough’ drug for PTSD patients
By Sara Chodosh August 29, 2017
Ecstasy doesn’t sound like something you do in a doctor’s office. But the Food and Drug Administration wants that to change. The FDA just approved the substance, more clinically known as MDMA, as a ‘breakthrough’ drug—and will work to move it through clinical trials as efficiently as possible.
The FDA only grants breakthrough status when a medication (for a serious disease) is likely to offer significantly better results than currently available treatments. It may seem wild that the same drug that EDM lovers take at raves is going to help soldiers recover from war-related trauma. But if you know how MDMA works, it shouldn’t come as a surprise.
http://www.popsci.com/fda-says-mdma-is-breakthrough-drug-for-ptsd-patients
